The Cat’s Meow: Wheeling Honors Slim Lehart for A long time of Leisure | Information, Sports activities, Jobs

Slim Lehart receives a congratulatory hug from Cynthia Johnson, Event Manager at the Capitol Theater outside the main entrance of the theater on Friday. (Photo by Scott McCloskey)

TO GO BIKING – “The rolling cat” gave herself a big birthday present on Friday.

On the day he turned 86, friends and fans stood at the entrance of the Capitol Theater to honor country icon Slim Lehart of Wheeling for his contributions to the music and the city. The town “Slim Lehart Day” April 2020, but the COVID-19 pandemic robbed Lehart of a public celebration on that day.

City officials gave him this long-awaited honor on Friday.

After an introduction by Frank O’Brien, Executive Director of the Wheeling Convention & Visitors Bureau, Wheeling Mayor Glenn Elliott read the proclamation for “Day of Lean Lehart”, that told some of his memorable exploits.

Lehart has had many great memories, particularly at the Capitol Theater where he was honored on Friday. This last celebration, he said, was an eternal memory.

“This is really about the best”, Lehart said “So that the locals come out and enjoy you and tell you what you did and how you helped in different areas.”

Born in Marshall County, Lehart moved to Wheeling at the age of 15. At 17 he joined the United States Navy and fought in the Korean War. Upon his return, his life began in country music.

He made his first appearance in 1965 for the Wheeling Jamboree at the Rex Theater. After that, he performed on accounts with country music legends for decades. He opened concerts for the Wheeling Jamboree and Jamboree USA almost every Saturday – but one of his fondest memories was in 1966 when Johnny Cash opened for him in Nashville.

He adopted the nickname “The rolling cat” of his signature song and captivated the audience with his energetic concerts. It wasn’t just a time to sing for him. It was a time to perform. A photo Lehart had saved on his cell phone showed him walking down a narrow stage in the center aisle of the Capitol Theater during a performance with all the audience’s eyes fixed on him.

“My style was active, very active” he said. “I was away from the stage and did all kinds of things. I did a show. “

Lehart and the Capitol Theater became synonymous. When the venue closed, he was at the forefront, fighting to reopen. O’Brien held up a photo at Friday’s event showing Lehart kneeling to kiss the stage after a performance in the reopened theater. When the theater was paid off, it was Lehart who was allowed to burn the mortgage papers.

“Talents and musicians like Slim Lehart, who are around 40 or 50 years old, created the stage for what we see today.” said O’Brien.

O’Brien added that Lehart’s stage presence and talent made him a great ambassador for entertainment for the town of Wheeling, playing a style that draws on the classic country artists.

“It’s authentic” he said. “I can’t think of any other word to describe it. It’s authentic country music that pays tribute to the genre’s roots. He has always stuck to this traditional approach. He never tried to modernize or rock it. “

After more than five decades of entertaining crowds from the Capitol to fairs, festivals, and parks, Lehart says he sometimes looks back on this life in music with amazement.

“It seems like I’m a different person” he said. “Well, it doesn’t seem like I did all that stuff. It’s a strange feeling. “

Yet it was him. And Wheeling wanted to make sure it was “Cat” received the admiration it deserves.

Get the latest news and more in your inbox

Gary Lineker on soccer kits all through the many years, film star fashion icons and his worst style catastrophe

Gary Lineker swaps football for fashion with his latest eyewear project.

Cary Grant was the first person who showed me how cool you can look with glasses, ”says the Match Of The Day presenter and former English soccer player who comes with a number of specs. revealed Vision Express “In this tortoiseshell frame, if anyone can remember? I think I’ll show my age a bit here … “

More than two decades since retiring from football, the 60-year-old says he’s been inspired by on-screen style icons and vintage fashion, but admits that there are some outfits from his own past that he’d rather forget …

The glasses shoot goes back to different decades, how does retro fashion influence your style?


“I would like to think that I am a long way from some of the retro fashion trends of the seventies and Eighties – the shell suits and the bright colors, although they were fun back then. I think retro fashion had an impact on my style, but mostly on items I know I can wear rather than entire looks.

“Sometimes I try to combine more classic items or vintage clothes with modern pieces, for example a leather jacket with a white top. I recently bought a Seventies-style All Saints jacket that I love. “

Gary Lineker wears glasses from the Lineker Edit for Vision Express

Who are your personal style icons?

“Outside of the sports world, I take a lot of style inspiration from movies or television, or at least I’ve tried over the years. I would say the likes of Sean Connery, Paul Newman and Don Draper from Mad Men are all style icons.

“Whether they are dressed in sharp, well-fitting suits or casual polo shirts, shirt and pullover layers or neutral slim-fit chinos, they look elegant, self-confident and timeless.”

Gary Lineker wears glasses from the Lineker Edit for Vision Express

Football shirts have developed a lot over the decades, which epochs did you like the most?

“Well, I went through the eighties when very short shorts were introduced. Some people definitely weren’t that keen on it, but I like a bit of freedom to walk around. Then we went into a phase of long shorts – I think we were the first team to wear them when I was at Tottenham.

“I really like retro football shirts and I think some of them are really cool, especially some of the lesser known ones. When I was in my early twenties we had an awful green striped one in Leicester, sponsored by Ind Coope. But one of my favorites would be something like an old classic 1970 World Cup Brazil [shirt]which is now probably a real collector’s item. “

Tottenham’s Gary Lineker speeds away from Arsenal’s David O’Leary during the 1991 Charity Shield match

What did you wear during the lockdown – did you get into the loungewear trend?

“Like most of the nation, I spent most of the lockdown in tracksuits. I didn’t just sit around in pajamas all day, I wore lots of sweatpants.

“Since playing soccer, I haven’t worn any tracksuits or sportswear, probably because it felt like I was wearing my old work clothes, and usually I mostly relaxed in jeans and t-shirts or jeans and casual shirts. But now it’s all about comfort, so tracksuits are again my first choice for relaxing. “

Do you have any fashion regrets from the past?

“My worst fashion disaster that I was thinking about recently was an outfit from the 1990s. After we lost to Germany in the World Cup semi-finals, I stayed in Italy to take the Fair Play Award trophy with Bobby Robson on behalf of the English team and for some inexplicable reason I went for a jacket that was really strong Stripes and then paired it with a big, noticeable, stained tie … It’s pretty appalling to say the least. “

In his role as Vision Express brand ambassador, Gary Lineker is launching Lineker Edit, an exclusive eyewear collection handpicked by Gary, available in-store and online from June 9th.

Biogen’s Alzheimer’s drug accepted by FDA, first new remedy in almost 20 years

The Food and Drug Administration approved on Monday BiogenicThe Alzheimer’s drug aducanumab is the first drug approved by the US authorities to slow cognitive decline in people with Alzheimer’s and the first new drug for the disease in almost two decades.

The FDA’s decision was eagerly awaited. The drug, which is marketed under the name Aduhelm, is also expected to generate billions in sales for the company offers new hope to friends and families of patients living with the disease.

“We are aware of the attention associated with this approval,” said Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, in a press release. “We know that Aduhelm has drawn the attention of the press, the Alzheimer’s patient community, our elected officials and other interested stakeholders.”

“With treatment for a serious, life-threatening disease in balance, it makes sense that so many people followed the outcome of this review,” added Cavazzoni.

The FDA said it would continue to monitor the drug when it hits the US market. The agency granted approval on the condition that Biogen conduct another clinical study.

Alzheimer’s disease is a progressive neurodegenerative disease that slowly destroys memory and thinking skills. More than 6 million Americans are reportedly living with it Alzheimer’s Association estimates. According to the group, this number is expected to rise to almost 13 million by 2050.

To date, there have been no FDA-approved drugs that can slow the mental decline of Alzheimer’s, the sixth leading cause of death in the United States. The agency has approved Alzheimer’s drugs that are aimed at relieving symptoms rather than slowing the disease itself down.

Federal agencies have come under intense pressure from friends and family members of Alzheimer’s patients to speed up aducanumab, but the road to regulatory approval has been controversial since it showed promise in 2016.

In March 2019, Biogen stopped work on the drug after analysis by an independent group found it was unlikely to work. The company then shocked investors a few months later by announcing that it would apply for regulatory approval for the drug after all.

Biogen’s shares rose in November after gaining support from FDA staff, who said the company had shown very “compelling” evidence of aducanumab’s effectiveness and that it had “an acceptable safety profile that would support its use in people with Alzheimer’s disease”.

But two days later, an external panel of experts advises the US authorities unexpectedly declined to support the experimental drug citing inconclusive data. It also criticized the agency’s staff for rating it too positively.

When Biogen filed for approval for the drug in late 2019, its scientists said a new analysis of a larger data set showed that aducanumab “reduces clinical decline in patients with early-stage Alzheimer’s disease.”

Alzheimer’s experts and Wall Street analysts were immediately skeptical, wondering whether the clinical trial data was enough to prove the drug works and whether approval could make it difficult for other companies to enroll patients in their own drug trials.

Some doctors said they won’t prescribe it the drug when it hits the market due to the mixed data package that supports the company’s application.

Supporters, including advocacy groups and family members of patients desperately looking for a new treatment, have admitted the data is not perfect. However, they argue that it could help some patients with Alzheimer’s, a progressive and debilitating disease.

Biogen’s drug targets a “sticky” compound in the brain known as beta-amyloid that scientists expect to play a role in the devastating disease. The company previously estimated that approximately 1.5 million people with early-stage Alzheimer’s in the United States could be candidates for the drug, according to Reuters.

The FDA’s decision is expected to reverberate across the biopharmaceutical sector, RBC Capital Markets analyst Brian Abrahams said in a June 1 announcement to customers.

The US agency said Monday that it had determined that there was “substantial evidence” that the drug was helping patients. “With Aduhelm approved by the FDA, an important and critical new treatment is available to patients with Alzheimer’s disease to combat the disease,” it said.